Quinn Yao

Quinn Yao, PhD has over 20 years of pharmaceutical experience in vaccines and AAV-based gene therapy product development and commercialization. He has strategic and strong technical leadership records in analytical/process development, analytical/process control strategies, CMC regulatory filings and project leadership.

Dr. Yao has expertise in early and late-stage analytical development, analytical control strategy, QC support and product commercialization for vaccines and biologics. His experience includes biochemical, biological/immunological assay development and cell-based assay development, validation, and transfer. He is an experienced project manager and has led cross-functional and cross-divisional teams in collaboration with CROs, CMOs & external partners in the US and outside the US. Dr. Yao has deep expertise in the cGMP environment and in CMC regulatory filings & regulatory agency interactions.

Quinn received his PhD in Molecular Virology & Immunology from the University of Maryland.